亚辉龙跌2.25%，成交额7973.41万元，主力资金净流出1573.80万元

Group 1 - The core viewpoint of the news is that Aihua Long's stock has experienced fluctuations, with a recent decline in price and significant net outflow of funds, indicating potential investor concerns [1] - As of January 15, Aihua Long's stock price was 15.24 yuan per share, with a total market capitalization of 8.708 billion yuan [1] - The company has seen a year-to-date stock price increase of 7.32%, but a decline of 3.61% over the last five trading days [1] Group 2 - Aihua Long's main business involves the research, production, and sales of in vitro diagnostic instruments and related reagents, with a revenue composition of 58.57% from self-produced reagents (non-COVID products) [1] - As of September 30, 2025, Aihua Long reported a revenue of 1.287 billion yuan, a year-on-year decrease of 7.69%, and a net profit of 60.42 million yuan, down 72.36% year-on-year [2] - The company has distributed a total of 693 million yuan in dividends since its A-share listing, with 531 million yuan distributed over the past three years [3]